Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10649 - 10656 of 12008 results
CMS Finalizes HIPAA and CLIA Amendments Intended to Increase Patient Access to Test Results
February 4, 2014| Blog| Viewpoint
The Affordable Care Act—Countdown to Compliance for Employers, Week 47: The Reporting Conundrum
February 3, 2014| Blog| Viewpoint
Tax Court Provides Color on “For Cause” Termination Under Code Section 83
February 3, 2014| Blog| Viewpoint
Departments of Labor, Health and Human Services and Treasury Issue Proposed Regulations Governing “Excepted Benefits”
February 3, 2014| Blog| Viewpoint
Could Bondholders Bring Claims Against Puerto Rico Bond Issuers in Courts Outside Puerto Rico?
February 3, 2014| Blog| Viewpoint
OIG Issues Favorable Opinion of Arrangement Containing Percentage-Based Compensation Structure
February 3, 2014| Blog| Viewpoint
Health Care Reform Goals Fail to Persuade Court in Antitrust Challenge to Acquisition
February 3, 2014| Blog| Viewpoint
Departments of Labor, Health and Human Services, and Treasury Issue Proposed Regulations Governing “Excepted Benefits”
February 3, 2014| Advisory| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|